Primary skin fibroblasts as a model of Parkinson's disease

  • Parkinson's disease is the second most frequent neurodegenerative disorder. While most cases occur sporadic mutations in a growing number of genes including Parkin (PARK2) and PINK1 (PARK6) have been associated with the disease. Different animal models and cell models like patient skin fibroblasts and recombinant cell lines can be used as model systems for Parkinson's disease. Skin fibroblasts present a system with defined mutations and the cumulative cellular damage of the patients. PINK1 and Parkin genes show relevant expression levels in human fibroblasts and since both genes participate in stress response pathways, we believe fibroblasts advantageous in order to assess, e.g. the effect of stressors. Furthermore, since a bioenergetic deficit underlies early stage Parkinson's disease, while atrophy underlies later stages, the use of primary cells seems preferable over the use of tumor cell lines. The new option to use fibroblast-derived induced pluripotent stem cells redifferentiated into dopaminergic neurons is an additional benefit. However, the use of fibroblast has also some drawbacks. We have investigated PARK6 fibroblasts and they mirror closely the respiratory alterations, the expression profiles, the mitochondrial dynamics pathology and the vulnerability to proteasomal stress that has been documented in other model systems. Fibroblasts from patients with PARK2, PARK6, idiopathic Parkinson's disease, Alzheimer's disease, and spinocerebellar ataxia type 2 demonstrated a distinct and unique mRNA expression pattern of key genes in neurodegeneration. Thus, primary skin fibroblasts are a useful Parkinson's disease model, able to serve as a complement to animal mutants, transformed cell lines and patient tissues.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Georg AuburgerORCiDGND, Michael Klinkenberg, Jessica Drost, Katrin Marcus, Blas Morales-Gordo, Wolfram S. Kunz, Ulrich BrandtORCiDGND, Vania Broccoli, Heinz Reichmann, Suzana Gispert, Marina Jendrach
URN:urn:nbn:de:hebis:30:3-279643
DOI:https://doi.org/10.1007/s12035-012-8245-1
ISSN:1559-1182
ISSN:0893-7648
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/22350618
Parent Title (English):Molecular neurobiology
Publisher:Humana Press
Place of publication:Totowa, NJ
Document Type:Article
Language:English
Date of Publication (online):2013/02/01
Date of first Publication:2012/02/19
Publishing Institution:Universit├Ątsbibliothek Johann Christian Senckenberg
Release Date:2013/02/01
Tag:PARK2; PARK6; PARK7; Parkinson's disease; Skin fibroblast; iPS
Volume:46
Page Number:8
First Page:20
Last Page:27
Note:
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
HeBIS-PPN:32257983X
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universit├Ątspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 3.0